Calm: coordinating a lung screening with mammography

SESSION TITLE: Lung Cancer Screening, Diagnosis and Staging SESSION TYPE: Original Investigations PRESENTED ON: 10/08/2023 08:15 am - 09:15 am PURPOSE: Lung cancer is the leading cause of cancer-related death in women. Despite clear evidence of benefit, multiple society recommendations and a USPSTF recommendation for lung cancer screening (LCS), uptake remains low. A recent study reported that nearly 70% of women who completed colon or breast cancer screening and were eligible for LCS had not been screened. The success of mammography implementation offers a unique opportunity to improve the uptake of lung screening for women who are screened for breast cancer. This American Cancer Society/National Lung Cancer Roundtable supported study was conducted to increase the uptake of LCS among breast cancer screening participants. METHODS: Mammogram participants from November 2019 – December 2022 in two academic hospitals were evaluated for potential eligibility for LCS. Electronic health record reports, outreach to primary care providers, advertisements and surveys completed at the time of mammography were utilized to identify eligible participants. Outreach was conducted to potentially eligible participants and/or referring providers to confirm eligibility and offer LCS. Women with metastatic malignancy or who were already enrolled in LCS were excluded. RESULTS: We reviewed 32,165 mammogram participants during the study period. Of those, 1,569 women were determined to be eligible for LCS and 1,089 (69%) of those had not previously been referred. After identification of potential LCS eligibility, patients and/or referring providers were notified. A significant increase in total LCS exams (annual + baseline) among women during the study period at both institutions was observed. Baseline LCS scans among women at the two institutions increased from 12 and 28 scans/month in the pre-study period to 18 and 38 scans/month during the study period (p value 0.0038 and 0.0125 respectively). There was not a corresponding significant change in baseline scans among men at either institution, increasing only from 16 to 17 scans/month and 32 to 36 scans/month (p=0.3089 and 0.1228 respectively). CONCLUSIONS: To improve early diagnosis and reduce mortality, it is imperative to identify mechanisms to increase LCS uptake. This study demonstrated a significant increase in LCS enrollment among women scheduled for screening mammography during the intervention period using targeted outreach with no significant change among men. Though the expanded 2021 United States Preventive Services Task Force LCS guidelines could have confounded the data, the stability of the male enrollment acting as a control, indicates that the observed increase among female patients can be attributed to the study intervention. CLINICAL IMPLICATIONS: Identifying potential LCS participants through current cancer screening programs, including mammography, offers a pathway for improved awareness and uptake of LCS in people who are already demonstrating screening behaviors. DISCLOSURES: No relevant relationships by Lipisha Agarwal No relevant relationships by Alaaeldin Ahmed No relevant relationships by Omar Al Omari No relevant relationships by Padmanabh Bhatt No relevant relationships by Stephen Deppen No relevant relationships by Landon Fike No relevant relationships by Caroline Godfrey No relevant relationships by Arulita Gupta No relevant relationships by Lauren Hatcher No relevant relationships by Chinmay Jani No relevant relationships by Shanna Joyner No relevant relationships by Ella Kazerooni No relevant relationships by Leila khorashadi No relevant relationships by Margaret Lotz No relevant relationships by Hannah Marmor No relevant relationships by Giulia Paliotti No relevant relationships by ALEXIS PAULSON No relevant relationships by Susan Pories No relevant relationships by Arashdeep Rupal Research grant relationship with American Cancer Society Please note: Current Added 03/29/2023 by Kim Sandler, source=Web Response, value=Grant/Research Support Advisory Committee Member relationship with RevealDx Please note: Current Added 03/29/2023 by Kim Sandler, source=Web Response, value=Consulting fee No disclosure on file for Robert Smith Editorial fee relationship with Springer Book - lung cancer screening Please note: 9/1/2022 Added 03/31/2023 by Carey Thomson, source=Web Response, value=Consulting fee author asthma card relationship with UpToDate Please note: current Added 03/31/2023 by Carey Thomson, source=Web Response, value=Royalty My spouse/partner as a Stock own relationship with Fulcrum Therapeutics Please note: current Added 03/31/2023 by Carey Thomson, source=Web Response, value=stock Consultant relationship with Median Technology Please note: 7/1/2022 Added 03/31/2023 by Carey Thomson, source=Web Response, value=Consulting fee No relevant relationships by Valerie Welty